Tummy Time for ILC2

Efthymia Kokkinou; Jenny Mjösberg

doi:10.1016/j.immuni.2020.03.008

Tummy Time for ILC2

Immunity. 2020 Apr 14;52(4):573-575. doi: 10.1016/j.immuni.2020.03.008.

Authors

Efthymia Kokkinou¹, Jenny Mjösberg²

Affiliations

¹ Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
² Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: jenny.mjosberg@ki.se.

PMID: 32294401
DOI: 10.1016/j.immuni.2020.03.008

Abstract

Little is known about host-microbiota interactions regulating anti-microbial immunity in the stomach. In this issue, Satoh-Takayama et al. describe an additional immune mechanism involving innate lymphoid cells type 2 (ILC2), which controls infection with Helicobacter pylori, a bacterium associated with inflammation and cancer.

Publication types

Comment

MeSH terms

Helicobacter pylori* / immunology
Immunity, Innate
Immunoglobulin A
Lymphocytes*
Stomach

Substances

Immunoglobulin A